Lipid incorporation inhibits Src-dependent assembly of fibronectin and type I collagen by vascular smooth muscle cells.
A vital role of vascular smooth muscle cells (SMCs) is to stabilize the artery wall by elaborating fibrils of type I collagen. This is especially important in atherosclerotic lesions. However, SMCs in these lesions can be laden with lipids and the impact of this modification on collagen fibril formation is unknown. To address this, we converted human vascular SMCs to a foam cell state by incubating them with either LDL or VLDL. Biochemical markers of a SMC phenotype were preserved. However, microscopic tracking revealed a profound perturbation in the ability of the cells to assemble collagen fibrils, reducing assembly by up to 79%. This dysfunction was mirrored by an inability of smooth muscle foam cells to assemble fibronectin. Lipid-loaded SMCs did not display a generalized defect in the actin cytoskeleton and the formation of vinculin-containing focal adhesion complexes was preserved. However, lipid-loaded SMCs were unable to assemble fibrillar adhesion complexes and clustering of tensin and alpha5beta1 integrin was disordered. Moreover, phosphorylation of tensin, required for fibrillar adhesion complex formation, was suppressed by up to 57%, with a concomitant decrease in activation of Src and FAK and restriction of activated Src to the cell edges. Forced activation of Src-FAK signaling in lipid-engorged SMCs rescued both fibrillar adhesion formation and fibrillogenesis. We conclude that lipid accumulation by SMCs disables the machinery for collagen and fibronectin assembly. This previously unknown relationship between atherogenic lipids and integrin-based signaling could underlie plaque vulnerability.
Frontini
Matthew J
MJ
Robarts Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada.
O'Neil
Caroline
C
Sawyez
Cynthia
C
Chan
Bosco M C
BM
Huff
Murray W
MW
Pickering
J Geoffrey
JG
D050197:Atherosclerosis / Q000201:enzymology* / Q000473:pathology; D002460:Cell Line; D024042:Collagen Type I / Q000378:metabolism*; D005353:Fibronectins / Q000378:metabolism*; D005487:Foam Cells / Q000201:enzymology; D051417:Focal Adhesion Kinase 1 / Q000378:metabolism; D022001:Focal Adhesions / Q000378:metabolism; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008079:Lipoproteins, VLDL / Q000378:metabolism*; D008840:Microfilament Proteins / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000201:enzymology* / Q000473:pathology; D032389:Myocytes, Smooth Muscle / Q000201:enzymology* / Q000473:pathology; D010316:Particle Size; D010641:Phenotype; D010766:Phosphorylation; D019030:Receptors, Vitronectin / Q000378:metabolism; D015398:Signal Transduction; D000070876:Tensins; D013997:Time Factors; D014161:Transduction, Genetic; D016596:Vinculin / Q000378:metabolism; D019061:src-Family Kinases / Q000235:genetics / Q000378:metabolism*
D024042:Collagen Type I; D005353:Fibronectins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D008840:Microfilament Proteins; D019030:Receptors, Vitronectin; D000070876:Tensins; C488955:VCL protein, human; C094340:integrin alphavbeta1; D016596:Vinculin; D051417:Focal Adhesion Kinase 1; C496050:PTK2 protein, human; D019061:src-Family Kinases